Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Caenorhabditis elegans provides an efficient drug screening platform for GNAO1 -related disorders and highlights the potential role of caffeine in controlling dyskinesia

Human Molecular Genetics(2021)10.1093/hmg/ddab296Source: DataRank Database

Caenorhabditis elegans provides an efficient drug screening platform for GNAO1 -related disorders and highlights the potential role of caffeine in controlling dyskinesia is a research paper published in Human Molecular Genetics (2021). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.20)OA: hybridTopics (33)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Serena Galosi ORCID,Enrico Lanza ORCID,Federica Tosato ORCID,Davide Caprini ORCID,Viola Folli

Live enrichment

PubMed:34622282 OpenAlex:https://openalex.org/W3203181195

Italian National Institute of Health

Grant: 2020-2022_ISS20-0ab01a06bd2a

National Research Council

Grant: NUTR-AGE-FOE2019-DSB.AD004.271

NIH HHS

Grant: P40 OD010440

FWCI

3.20

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://academic.oup.com/hmg/article-pdf/31/6/929/42993564/ddab296.pdf

publisherhttps://academic.oup.com/hmg/article-pdf/31/6/929/42993564/ddab296.pdf

publisherhttps://academic.oup.com/hmg/advance-article-pdf/doi/10.1093/hmg/ddab296/41108489/ddab296.pdf

journalhttps://doi.org/10.1093/hmg/ddab296

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34622282

Fields of Study

Genetics, Aging, and Longevity in Model OrganismsCRISPR and Genetic EngineeringPancreatic function and diabetesAcetylcholinesteraseAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCaffeineDrug Evaluation, PreclinicalDyskinesiasGTP-Binding Protein alpha Subunits, Gi-GoGTP-Binding ProteinsMutationNeurotransmitter Agents

MeSH Terms

AcetylcholinesteraseAnimalsCaffeineDrug Evaluation, PreclinicalMutationCaenorhabditis elegansNeurotransmitter AgentsGTP-Binding ProteinsGTP-Binding Protein alpha Subunits, Gi-GoDyskinesiasCaenorhabditis elegans Proteins

Keywords

BiologyCaenorhabditis elegansHaploinsufficiencyMutantGeneticsPhenotypePharmacologyGene